Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The amygdala is an almond-shaped group of nuclei located deep within the temporal lobe of the brain. It is a principal component of the limbic system and is essential for the processing of emotions, including fear, anxiety, and aggression, as well as for emotional learning and memory. The amygdala consists of multiple subnuclei (including basolateral, central, medial, and cortical nuclei), each with distinct connections, functions, and cell-type compositions. Its dysfunction or abnormal structure is linked to neuropsychiatric disorders, including anxiety disorders, PTSD, depression, and autism spectrum disorders. The amygdala is not a single molecular entity but a highly complex anatomical and functional region, which receives and sends projections to many areas of the brain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amygdala.